Latest News of BLFS
BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q2
Conestoga Capital Advisors' Q2 2024 investor letter discusses the market moderation, with small-cap stocks underperforming. BioLife Solutions, Inc. (NASDAQ:BLFS) was highlighted as a top pick with a s...
A Look At The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
The analyst price target for BLFS is slightly higher than the fair value estimate. Using a discounted cash flow model, the company's value is calculated to be US$1.1b, indicating the stock is trading ...
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
Todd Berard, CMO of BioLife Solutions Inc (NASDAQ:BLFS), sold 10,000 shares on June 14, 2024. Berard now holds 108,894 shares. BioLife specializes in bioproduction tools for cell and gene therapies....